Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1285 | 1076 | 1285 | 1207 | 1607 | 2389 |
Fund Return | 28.48% | 7.59% | 28.48% | 6.47% | 9.95% | 9.1% |
Place in category | 637 | 740 | 637 | 402 | 367 | 138 |
% in Category | 10 | 11 | 10 | 8 | 10 | 8 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Swisscanto CH IPF I Index Equity Fu | 7.6B | 28.23 | 7.73 | 9.68 | ||
Swisscanto CH IPF III Index EquAST | 5.43B | 28.29 | 7.43 | 9.36 | ||
CH0296590281 | 2.58B | 20.31 | 6.94 | - | ||
Swisscanto CH IPF I Index Equity CH | 2.59B | 28.80 | 6.81 | 9.49 | ||
CH0315621927 | 1.85B | 12.15 | -3.13 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0429081620 | 8.08B | 28.56 | 7.62 | - | ||
Swisscanto CH IPF I Index Equity Fu | 7.6B | 28.23 | 7.73 | 9.68 | ||
CH0337393745 | 6.8B | 27.50 | 7.27 | - | ||
Swisscanto CH IPF III Index EquAST | 5.43B | 28.29 | 7.43 | 9.36 | ||
UBS CH Institutional Fund 2 EquiPAX | 4.48B | 28.90 | 6.79 | 9.56 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
iShares MSCI USA UCITS | IE00B52SFT06 | 26.90 | 595.72 | -1.51% | |
Xtrackers MSCI USA UCITS ETF 1C | IE00BJ0KDR00 | 26.89 | 165.90 | -0.96% | |
UBS Irl plc MSCI USA A-acc | IE00BD4TXS21 | 18.75 | 33.72 | -1.32% | |
Amundi Prime USA UCITS USD Acc | IE000FSN19U2 | 1.89 | 36.49 | -0.98% | |
E-mini S&P 500 Future Dec 24 | - | 0.85 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review